Mealey's (June 8, 2020, 7:05 AM EDT) -- LEXINGTON, Ky. — In a May 26 order, a Kentucky federal magistrate judge denied a motion for a supplemental protective order by Bristol-Myers Squib Co. (BMS) and AstraZeneca Pharmaceuticals LP (AZ) in a multidistrict litigation over two diabetes drugs, finding an existing order sufficient to address confidentiality concerns over the submission of clinical trial data (In re: Onglyza and Kombliglyze XR Products Liability Litigation, No. 5:18-md-02809, E.D. Ky., 2020 U.S. Dist. LEXIS 91005)....